| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00259-010-1613-Z |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/s00259-010-1613-z.pdf |
| http://link.springer.com/article/10.1007/s00259-010-1613-z/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/s00259-010-1613-z | ||
| P698 | PubMed publication ID | 20878403 |
| P5875 | ResearchGate publication ID | 46580496 |
| P50 | author | Nobuyuki Oyama | Q59696088 |
| P2093 | author name string | Masato Kobayashi | |
| Yoko Hasegawa | |||
| Yasuhisa Fujibayashi | |||
| Osamu Yokoyama | |||
| Yasushi Kiyono | |||
| Carmen Dence | |||
| Michael J. Welch | |||
| Datta E. Ponde | |||
| P2860 | cites work | Cancer statistics, 2009 | Q29547625 |
| Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer | Q29616123 | ||
| Epothilone B and its analogs - a new family of anticancer agents | Q30767164 | ||
| PET imaging of prostate cancer using carbon-11-choline. | Q34471810 | ||
| Chemotherapy for prostate carcinoma | Q39528613 | ||
| Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone. | Q39848186 | ||
| Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate | Q40508389 | ||
| Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. | Q40813713 | ||
| Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study. | Q43125970 | ||
| FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. | Q43707212 | ||
| Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers | Q43830072 | ||
| 11C-acetate PET imaging of prostate cancer. | Q43890716 | ||
| Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. | Q44018378 | ||
| 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. | Q44030329 | ||
| Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. | Q44128080 | ||
| Early changes in [18F]FLT uptake after chemotherapy: an experimental study | Q44192327 | ||
| In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumor | Q44214948 | ||
| MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model | Q44230664 | ||
| Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis | Q44551103 | ||
| Using Positron Emission Tomography 2-Deoxy-2-[18F]Fluoro-D-Glucose, 11CO, and 15O-Water for Monitoring Androgen Independent Prostate Cancer | Q44589733 | ||
| Utilization of labeled thymidine in DNA synthesis: studies for PET. | Q45184798 | ||
| Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. | Q46872269 | ||
| Measurement of [methyl-carbon-11]thymidine and its metabolites in head and neck tumors. | Q49106099 | ||
| Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. | Q54117465 | ||
| Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose | Q70956697 | ||
| The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer | Q73559459 | ||
| Performance evaluation of the microPET P4: a PET system dedicated to animal imaging | Q74272637 | ||
| Carbon-11-thymidine and FDG to measure therapy response | Q77425014 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | docetaxel | Q420436 |
| prostate carcinoma | Q18553829 | ||
| Dideoxynucleosides | Q76529965 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 81-89 | |
| P577 | publication date | 2010-09-29 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models | |
| Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models | |||
| P478 | volume | 38 |
| Q41008780 | An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3'-deoxy-3'[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma |
| Q38475122 | Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models. |
| Q61455998 | Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma |
| Q28066696 | Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography |
| Q36129937 | Molecular imaging of prostate cancer: PET radiotracers |
| Q26778463 | Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studies |
| Q37390670 | PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer |
| Q36308766 | PET/CT in prostate cancer: non-choline radiopharmaceuticals |
| Q37962869 | Prospects in radionuclide imaging of prostate cancer |
| Q37244969 | Translational Molecular Imaging of Prostate Cancer |
| Q36236041 | [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. |
| Q38939387 | [18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells |
Search more.